Clinical Trials Logo

Coronary Artery Disease clinical trials

View clinical trials related to Coronary Artery Disease.

Filter by:

NCT ID: NCT04185493 Recruiting - Clinical trials for Coronary Artery Disease

Coronary Artery Geometry and the Severity of Coronary Atherosclerosis

GEOMETRY-CTA
Start date: June 4, 2020
Phase:
Study type: Observational [Patient Registry]

The purpose of this study is to investigate the potential association of coronary artery geometry, based on coronary CT angiography (CCTA), with the complexity and the severity of coronary atherosclerosis.

NCT ID: NCT04185285 Recruiting - Clinical trials for Coronary Artery Disease

Percutaneous Coronary Intervention Registry FRIBOURG

Cardio-FR
Start date: May 1, 2015
Phase:
Study type: Observational [Patient Registry]

The registry aims to follow clinically all consecutive patients treated by percutaneous coronary interventions at hospital & university Fribourg.

NCT ID: NCT04181268 Recruiting - Clinical trials for Coronary Artery Disease

ROtational Atherectomy, Lithotripsy or LasER for the Treatment of CAlcified STEnosis

ROLLERCOASTR
Start date: November 15, 2020
Phase: N/A
Study type: Interventional

Some data exist about the efficacy and safety of rotational atherectomy, intravascular lithotripsy and excimer laser to modify calcified plaques. However there is no direct randomized comparison between these three tools in this scenario. The aim of this pilot randomized trial is to compare the safety and efficacy of these three techniques during PCI of moderate to severe calcified lesions.

NCT ID: NCT04179045 Not yet recruiting - Clinical trials for Coronary Artery Disease

A Registry Trial of The Bioheart Rapamycin Drug-Eluting Bioresorbable Coronary Stent System

Start date: March 1, 2021
Phase: N/A
Study type: Interventional

This study is a prospective, multi-center single arm registry trial, planning to enroll 785 subjects. All subjects will receive clinical follow-up at 1 month, 6 month, 9 month and 1, 2, 3, 4, 5 year after index procedure. The primary endpoint will be target lesion failure (TLF) at 1 year after index procedure,which will be analyzed to evaluate the efficacy and safety of the device.

NCT ID: NCT04176978 Withdrawn - Atherosclerosis Clinical Trials

PsA T2T Statin Trial on Carotid and Coronary Atherosclerosis

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

Psoriatic arthritis (PsA) is a chronic inflammatory disease associated with an increased risk of myocardial infarction (MI). Using coronary computer tomography angiogram (CCTA), it is found that a significantly higher prevalence of high-risk coronary plaque (non-calcified plaque [NCP]), supporting the notion that more aggressive cardiovascular (CV) evaluation strategy should be considered in these patients. Carotid ultrasound screening in this population may be a better alternative than traditional risk score to identify patients at high CV risk as the latter underestimated CV risk. Previous study from our group have demonstrated that achieving treatment target (minimal disease activity [MDA]) can prevent progression of carotid atherosclerosis. Nevertheless, 38% of this Treat to Target (T2T) cohort still had carotid plaque progression. Project description it is hypothesized that combination of a T2T stratgy together with high-intensity rosuvastatin treatment (Group 1: T2T-statin group) is more effective in preventing progression of coronary and carotid atherosclerosis than T2T stratgy alone (Group 2: T2T-only group) in high-risk PsA patients with carotid plaque. The primary outcome is to ascertain the effect of T2T strategy with high-intensity rosuvastain (Group 1: T2T-statin group) on the change in CIMT over a period of 12 months compared with T2T strategy alone (Group 2: T2T-only group)

NCT ID: NCT04175626 Active, not recruiting - Clinical trials for Coronary Artery Disease

Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

BIOFLOW-VII
Start date: January 24, 2020
Phase:
Study type: Observational

The objective of this post-approval study is to confirm that the clinical performance of the Orsiro stent in a real-world setting is similar to the clinical performance observed for Orsiro in the BIOFLOW-V Investigational Device Exemption pivotal trial, as a condition of the US Food and Drug Administration (FDA) approval (P170030).

NCT ID: NCT04172974 Recruiting - Depression, Anxiety Clinical Trials

eHealth Intervention to Manage Depression and Anxiety in Patients With Ischemic Heart Disease

eMYHeart
Start date: June 1, 2020
Phase: N/A
Study type: Interventional

This study evaluates the effectiveness and cost-effectiveness of a therapy-assisted internet-based intervention in patients with ischemic heart disease and co-morbid depression and anxiety referred for cardiac rehabilitation. Half of the patients will receive the intervention and the other half usual care. We hypothesize that the intervention will lead to a reduction in patients' symptoms of depression and anxiety and be cost-effective.

NCT ID: NCT04172870 Active, not recruiting - Clinical trials for Coronary Artery Disease

Evaluation of Inflammatory Markers and Periodontal Viruses on Periodontitis Patients With CAD

Start date: November 15, 2018
Phase:
Study type: Observational

To assess and compare the demographic variables, periodontal parameters, cardiac parameters and the expression of periodontal viruses (CMV, HSV and EBV) and inflammatory biomarkers(PTX-3, TLR-2 & TLR-4) in periodontally healthy and generalized periodontitis patients with and without coronary artery disease(CAD).

NCT ID: NCT04163484 Recruiting - Clinical trials for Coronary Artery Disease

Contrast-associated Acute Kidney Injury in Patients With Different Types of Coronary Artery Disease

Start date: January 15, 2019
Phase:
Study type: Observational

The goal of the study is to assess the prevalence of contrast-associated acute kidney injury in patients with stable coronary artery disease, ST-elevation myocardial infarction and unstable angina/NSTEMI, assess the risk factors of contrast-induced acute kidney injury development and the influence of contrast-induced kidney injury on 1-year prognosis.

NCT ID: NCT04163471 Completed - Clinical trials for Coronary Artery Disease

VasoStat vs. TR Band for Radial Hemostasis

Start date: June 4, 2018
Phase:
Study type: Observational

VasoStat vs. TR Band compression for Radial Artery Hemostasis Following Transradial Catheterization Without Prior Radial Artery Access